NES Transdermal Spray

Product Overview

Alternative Name: Nestorone (NES) Metered Dose Transdermal System® (MDTS®)

Development Status: Inactive

Target: Female

Mode: Hormonal

Delivery Type: Transdermal

Duration Type: Short-acting

Description: A transdermal spary, using the Metered Dose Transdermal System developed by Acrux, Ltd., containing nestorone (NES) and potentially an estrogen (either EE or E2). The spray delivers drugs to the skin surface and with the aid of safe enhancers, forms a reservoir within the skin from which the drug is slowly absorbed into circulation over a period of many hours (up to 72 hours).

Updated date: May 30, 2018

Vertical Tabs

Status

Project Phase: Early Development

Project Stage: Phase I

Began discovery in: 2003

Status Details:
  • The company developing the spray was no longer interested in developing the formulation and abandoned the project.

Download Product Report